PUMA

academical publication management
collect, organize, and share publications

( en | de )

 

Disambiguation of "Reiche, Kristin"

Author of the publication

copydeleteadd this publication to your clipboard
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology

, , , , , , , , , and . npj Precision Oncology, (January 2024)
DOI: 10.1038/s41698-024-00517-w

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Reiche, Kristin
add a person with the name Reiche, Kristin
 

Other publications of authors with the same name

Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?, , , , , , , , , and 136 other author(s). European Urology Open Science, (January 2024)Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?, , , , , , , , , and 18 other author(s). Journal for ImmunoTherapy of Cancer, 10 (5): e003487 (May 2022)Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma, , , , , , , , , and 19 other author(s). Leukemia, 38 (2): 372--382 (Feb 1, 2024)Atypical fibroxanthoma and pleomorphic dermal sarcoma – gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma, , , , , , , , , and 1 other author(s). JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 21 (5): 482–491 (April 2023)Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer, , , , , , , , , and 8 other author(s). BMC Cancer, (June 2023)Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody, , , , , , , , , and 13 other author(s). Nature Medicine, 31 (4): 1145--1153 (Apr 1, 2025)Transcriptomic signatures reveal a shift towards an anti-inflammatory gene expression profile but also the induction of type I and type II interferon signaling networks through aryl hydrocarbon receptor activation in murine macrophages, , , , , , , , , and . Frontiers in Immunology, (May 2023)Teclistamab impairs detection of BCMA CAR-T cells, , , , , , , , , and 8 other author(s). Blood Advances, 7 (15): 3842–3845 (July 2023)Prognostic implications of splenomegaly in BCMA-directed CAR T-Cell therapy for relapsed myeloma, , , , , , , , , and 13 other author(s). Transplantation and Cellular Therapy, (July 2025)Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma, , , , , , , , , and 23 other author(s). Nature Cancer, 5 (9): 1318–1333 (April 2024)